A citation-based method for searching scientific literature

Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration.
Y H Gong, A S Parsadanian, A Andreeva, W D Snider, J L Elliott. J Neurosci 2000
Times Cited: 256



Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.
Lindsey R Fischer, Deborah G Culver, Philip Tennant, Albert A Davis, Minsheng Wang, Amilcar Castellano-Sanchez, Jaffar Khan, Meraida A Polak, Jonathan D Glass. Exp Neurol 2004
Times Cited: 951




List of shared articles



Times cited

The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis.
Oihane Pikatza-Menoio, Amaia Elicegui, Xabier Bengoetxea, Neia Naldaiz-Gastesi, Adolfo López de Munain, Gorka Gerenu, Francisco Javier Gil-Bea, Sonia Alonso-Martín. J Pers Med 2021
9

Progressive Mitochondrial SOD1G93A Accumulation Causes Severe Structural, Metabolic and Functional Aberrations through OPA1 Down-Regulation in a Mouse Model of Amyotrophic Lateral Sclerosis.
Iago Méndez-López, Francisco J Sancho-Bielsa, Tobias Engel, Antonio G García, Juan Fernando Padín. Int J Mol Sci 2021
5

Glial Cells-The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment.
Tereza Filipi, Zuzana Hermanova, Jana Tureckova, Ondrej Vanatko, And Miroslava Anderova. J Clin Med 2020
33

Human Motor Neurons With SOD1-G93A Mutation Generated From CRISPR/Cas9 Gene-Edited iPSCs Develop Pathological Features of Amyotrophic Lateral Sclerosis.
Byung Woo Kim, Jiwon Ryu, Ye Eun Jeong, Juhyun Kim, Lee J Martin. Front Cell Neurosci 2020
10

Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome.
Lee J Martin, Margaret Wong. Front Neurol 2020
21

Targeting Macrophage for the Treatment of Amyotrophic Lateral Sclerosis.
Lian Li, Jie Liu, Hua She. CNS Neurol Disord Drug Targets 2019
2

The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives.
Julio-César García, Rosa-Helena Bustos. Brain Sci 2018
15

Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.
Valentina Cappello, Maura Francolini. Int J Mol Sci 2017
50

From animal models to human disease: a genetic approach for personalized medicine in ALS.
Vincent Picher-Martel, Paul N Valdmanis, Peter V Gould, Jean-Pierre Julien, Nicolas Dupré. Acta Neuropathol Commun 2016
86

Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.
Kristopher G Hooten, David R Beers, Weihua Zhao, Stanley H Appel. Neurotherapeutics 2015
171

Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic.
Renzo Mancuso, Xavier Navarro. Prog Neurobiol 2015
75

Rodent Models of Amyotrophic Lateral Sclerosis.
Thomas Philips, Jeffrey D Rothstein. Curr Protoc Pharmacol 2015
152

Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.
C Veyrat-Durebex, P Corcia, A Dangoumau, F Laumonnier, E Piver, P H Gordon, C R Andres, P Vourc'h, H Blasco. Mol Neurobiol 2014
14

Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS).
Lindsay Poppe, Laura Rué, Wim Robberecht, Ludo Van Den Bosch. Exp Neurol 2014
40

Transcriptome Profiling Following Neuronal and Glial Expression of ALS-Linked SOD1 in Drosophila.
Emily L Kumimoto, Taylor R Fore, Bing Zhang. G3 (Bethesda) 2013
17

Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.
Aikaterini Nanou, Adrian Higginbottom, Chiara F Valori, Matthew Wyles, Ke Ning, Pamela Shaw, Mimoun Azzouz. Mol Ther 2013
30

Quantity and activation of myofiber-associated satellite cells in a mouse model of amyotrophic lateral sclerosis.
Raquel Manzano, Janne M Toivonen, Ana Cristina Calvo, Sara Oliván, Pilar Zaragoza, Maria Jesús Muñoz, Didier Montarras, Rosario Osta. Stem Cell Rev Rep 2012
11

The complex molecular biology of amyotrophic lateral sclerosis (ALS).
Rachel L Redler, Nikolay V Dokholyan. Prog Mol Biol Transl Sci 2012
105

The Role of the Innate Immune System in ALS.
Sudarshan Phani, Diane Berengere Re, Serge Przedborski. Front Pharmacol 2012
35

Motor neuron trophic factors: therapeutic use in ALS?
Thomas W Gould, Ronald W Oppenheim. Brain Res Rev 2011
48

Stronger is not always better: could a bodybuilding dietary supplement lead to ALS?
Marin Manuel, C J Heckman. Exp Neurol 2011
6

Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis.
Bianca Heurich, Nawal Bahia El Idrissi, Rossen M Donev, Susanne Petri, Peter Claus, James Neal, B Paul Morgan, Valeria Ramaglia. J Neuroimmunol 2011
43

Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis.
Eveliina Pollari, Ekaterina Savchenko, Merja Jaronen, Katja Kanninen, Tarja Malm, Sara Wojciechowski, Toni Ahtoniemi, Gundars Goldsteins, Raisa Giniatullina, Rashid Giniatullin,[...]. J Neuroinflammation 2011
50

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.
Laura Ferraiuolo, Janine Kirby, Andrew J Grierson, Michael Sendtner, Pamela J Shaw. Nat Rev Neurol 2011
412

Inflammation in ALS and SMA: sorting out the good from the evil.
Dimitra Papadimitriou, Virginia Le Verche, Arnaud Jacquier, Burcin Ikiz, Serge Przedborski, Diane B Re. Neurobiol Dis 2010
101

Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
Bradley J Turner, Steven Ackerley, Kay E Davies, Kevin Talbot. Hum Mol Genet 2010
40

Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.
Margaret Wong, Lee J Martin. Hum Mol Genet 2010
225

Nerve terminal degeneration is independent of muscle fiber genotype in SOD1 mice.
Dario I Carrasco, Edyta K Bichler, Kevin L Seburn, Martin J Pinter. PLoS One 2010
14


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy